Annual report pursuant to Section 13 and 15(d)

Intangibles - Summary Of The JMC Intangible Asset (Details)

v3.19.1
Intangibles - Summary Of The JMC Intangible Asset (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Net intangible assets $ 1,417 $ 883
Journey Medical Corporation [Member]    
Finite-Lived Intangible Assets, Gross 2,800 1,600
Accumulated amortization 1,383 717
Net intangible assets $ 1,417 883
Ceracade [Member] | Journey Medical Corporation [Member]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Finite-Lived Intangible Assets, Gross $ 300 300
Luxamend [Member] | Journey Medical Corporation [Member]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Finite-Lived Intangible Assets, Gross $ 50 50
Targadox [Member] | Journey Medical Corporation [Member]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Finite-Lived Intangible Assets, Gross $ 1,250 1,250
Exelderm [Member] | Journey Medical Corporation [Member]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Finite-Lived Intangible Assets, Gross $ 1,200 $ 0